Digestive system malignant
tumors are common
tumors, and the traditional treatment methods for these
tumors include surgical resection,
radiotherapy,
chemotherapy, and molecularly targeted drugs. However, diagnosis remains challenging, and the early detection of postoperative recurrence is complicated. Therefore, it is necessary to explore novel
biomarkers to facilitate clinical diagnosis and treatment. Accumulating evidence supports the crucial role of
chloride channels in the development of multiple types of
cancers. Given that
chloride channels are widely expressed and involved in cell proliferation, apoptosis and cell cycle, among other processes, they may serve as a promising diagnostic and therapeutic target.
Chloride intracellular channels (CLICs) are a class of
chloride channels that are upregulated or downregulated in certain types of
cancer. Furthermore, in certain cases, during cell cycle progression, the localization and function of the cytosolic form of the transmembrane
proteins of CLICs are also altered, which may provide a key target for
cancer therapy. The aim of the present review was to focus on CLICs as
biomarkers for digestive system
tumors.